CD8A and neoplasm: Conventional CD4+ T cells, which promote anti-tumor immune responses and cytotoxic effects, inhibit tumor growth by secreting interferon-γ (IFN-γ) and tumor necrosis factor (TNF), whereas tumor-resident Tregs have been shown to suppress the infiltration and anti-tumor activities of effector CD8+ T cells (26).